PAPPA and COVID-19: We found that plasma levels of IMA and PAPP-A in the early phase of SARS-CoV-2 infection were significantly higher than in the control subjects, and so we propose that measuring the level of IMA and PAPP-A from the incipience can be useful in detecting early stages of the disease and managing COVID-19.